2017 Biochemistry Golf Day

15 June 2017|0 Comments

It was a dreary day on June 13th but it would take more than a few showers to dampen the spirits of 24 intrepid biochemists who headed out to the Flemingdon Park 9-hole Golf Course in Midtown Toronto for our annual Golf Day. Each team had its share of beginners and ringers playing a “best ball” […]

  • Group Photo 2016

2016 Biochemistry Retreat at Geneva Park

27 August 2016|0 Comments

On August 25th and 26th, the Biochemistry Department held its first Retreat outside of Toronto at the Geneva Park Conference Centre near Orillia.

The turnout was terrific with 140 trainees, staff and Faculty gathering for two days to celebrate the science that we do and to enjoy each other’s company in a beautiful lakeside setting. The […]

  • Group shot

2016 Biochemistry Golf Day

9 August 2016|0 Comments

August 9th dawned hot and steamy but that didn’t deter our hardy biochemists from heading out to Flemingdon Park 9-hole Golf Course in Midtown Toronto for our annual Golf Day. Each team had its share of beginners and ringers playing a “best ball” format that allowed everyone to contribute to their team. Despite the 32 […]

  • Prosser and Ernst Lab

Understanding the Molecular Underpinnings of Cell Signaling through GPCRs

17 May 2016|0 Comments

A class of receptors responsible for regulating neuronal function is part of the focus of a recent study by the Prosser and Ernst labs at UofT. Their paper, “Activation of the A2A adenosine G-protein-coupled receptor by conformational selection,” appears in the latest edition of the journal Nature http://www.nature.com/nature/journal/vaop/ncurrent/full/nature17668.html.

There is a great deal of interest in understanding this broad class of […]

  • Prion FKBP summary small

Williams lab unravels the mechanistic basis of a treatment for prion diseases

3 March 2016|0 Comments

Prion disease occurs when the normal cellular prion protein (PrPC) is misfolded by a pathogenic form of the protein termed PrP scrapie (PrPSc). One approach to treat prion diseases is to reduce or eliminate PrPC since mice lacking this protein show few ill effects. The human-approved immunosuppressive drug FK506 has been shown to extend survival in […]